Abstract

ObjectiveTo investigate the molecular characteristics of extended-spectrum cephalosporin (ESC)-resistant Enterobacteriaceae collected during a cross-sectional study examining the prevalence and risk factors for faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in humans living in areas with high or low broiler density.MethodsESC-resistant Enterobacteriaceae were identified by combination disc-diffusion test. ESBL/AmpC/carbapenemase genes were analysed using PCR and sequencing. For E. coli, phylogenetic groups and MLST were determined. Plasmids were characterized by transformation and PCR-based replicon typing. Subtyping of plasmids was done by plasmid multilocus sequence typing.Results175 ESC-resistant Enterobacteriaceae were cultured from 165/1,033 individuals. The isolates were Escherichia coli(n=65), Citrobacter freundii (n=52), Enterobacter cloacae (n=38), Morganella morganii (n=5), Enterobacter aerogenes (n=4), Klebsiella pneumoniae (n=3), Hafnia alvei (n=2), Shigella spp. (n=2), Citrobacter amalonaticus (n=1), Escherichia hermannii (n=1), Kluyvera cryocrescens (n=1), and Pantoea agglomerans (n=1). The following ESBL genes were recovered in 55 isolates originating from 49 of 1,033 (4.7 %) persons: bla CTX-M-1 (n=17), bla CTX-M-15 (n=16), bla CTX-M-14 (n=9), bla CTX-M-2 (n=3), bla CTX-M-3 (n=2), bla CTX-M-24 (n=2), bla CTX-M-27 (n=1), bla CTX-M-32 (n=1), bla SHV-12 (n=2), bla SHV-65 (n=1) and bla TEM-52 (n=1). Plasmidic AmpC (pAmpC) genes were discovered in 6 out of 1,033 (0.6 %) persons. One person carried two different E. coli isolates, one with bla CTX-M-1 and the other with bla CMY-2 and therefore the prevalence of persons carrying Enterobacteriaceae harboring ESBL and/or pAmpC genes was 5.2 %. In eight E. coli isolates the AmpC phenotype was caused by mutations in the AmpC promoter region. No carbapenemase genes were identified. A large variety of E. coli genotypes was found, ST131 and ST10 being most common.ConclusionsESBL/pAmpC genes resembled those from patients in Dutch hospitals, indicating that healthy humans form a reservoir for transmission of these determinants to vulnerable people. The role of poultry in the transmission to humans in the community remains to be elucidated.

Highlights

  • Extended-spectrum-β-lactamase/AmpC producing Enterobacteriaceae have been found among humans worldwide

  • 175 extended spectrum cephalosporins (ESC)-resistant Enterobacteriaceae were cultured from 165/1,033 individuals

  • The following ESBL genes were recovered in 55 isolates originating from 49 of 1,033 (4.7 %) persons: blaCTX-M-1 (n=17), blaCTX-M-15 (n=16), blaCTX-M-14 (n=9), blaCTX-M-2 (n=3), blaCTX-M-3 (n=2), blaCTX-M-24 (n=2), blaCTX-M-27 (n=1), blaCTX-M-32 (n=1), blaSHV-12 (n=2), blaSHV-65 (n=1) and blaTEM-52 (n=1)

Read more

Summary

Introduction

Extended-spectrum-β-lactamase/AmpC producing Enterobacteriaceae have been found among humans worldwide. Most large-scale studies in humans, report data of patients or travelers and/or focus on ESBL-producing bacteria and/or certain bacterial species only (e.g. Escherichia coli or Klebsiella pneumoniae) [1,2,3,4]. Data on the prevalence of fecal carriage of ESBL/AmpC/carbapenemase producing Enterobacteriaceae in healthy humans in the community are scarce. In 2011, a cross-sectional study was performed to determine the prevalence of, and identify risk factors for, carriage of ESBL-producing Enterobacteriaceae in people living in municipalities with either high or low broiler densities [14]. The prevalence of carriage of ESBL-producing bacteria was 5.1% and this percentage was lower in municipalities with high broiler densities (3.6%) compared to municipalities with low broiler densities (6.7%) [14]. The aim of the present study was to analyse the isolates from this cross-sectional study, including isolates with an AmpC phenotype, with respect to molecular characteristics and compare them to published data on isolates from patients, broilers, and persons in contact with broilers

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.